Aetna Hits 52-Week High On Strong Q3, Star Rating Action

 | Nov 22, 2016 09:09PM ET

On Nov 22, 2016, the stock of Aetna Inc. (NYSE:AET) climbed to a 52-week high of $128.73. The upside in the stock is believed to have been driven by a profitable third quarter reported last month and favorable medicare star rating action.

Over the past 52-weeks, the stock gained 23% compared with a rise of just 5.5% in the S&P 500 index over the same period.

Investors favorably viewed the company’s third-quarter results, which witnessed broad-based revenue and earnings growth.

The quality of earnings was strong as evident by revenue growth of 5% year over year to $15.7 billion. The company’s adjusted earnings per share grew 9% to $2.07 per share and surpassed the Zacks Consensus Estimate of $2.02.

Investors also appreciated management’s cost reducing drive which lowered the adjusted operating expense ratio to 17.6% from 18.6% in the year-ago quarter.

It is noteworthy that the company’s Government business, which includes Medicare and Medicaid, is performing strongly. The company has been witnessing an increase in top line and enrollment in this line of business over the past many quarters and government premiums now represent nearly 50% its total health care premiums. The government business presents a strong growth potential given the ever-increasing demand for its products from the growing baby boomers population.

The rise in share price must also have been favored by a positive tone on the third-quarter earnings conference call regarding the expectation of continued strong performance in the fourth quarter and into 2017. The company continues to expect strong operating performance in its core businesses and raised its operating EPS projection to $7.95 to $8.05 per share.

AETNA INC-NEW Price and Consensus

the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here .

Another player from the same industry Tenet Healthcare Corporation (NYSE:THC) , however, fell to a 52-week low earlier during the month following its third-quarter earnings release which revealed poor performance and weak guidance. Tenet Healthcare carries a Zacks Rank #3 (Hold).

Zacks' Top Investment Ideas for Long-Term Profit

How would you like to see our best recommendations to help you find today’s most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Zacks Investment Research

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes